A novel multi-strain probiotic and synbiotic supplement for prevention of Clostridium difficile infection in a murine model.
(2014) In Microbiology and Immunology 58(10). p.552-558- Abstract
 - The protective effect of a multi-strain probiotic and synbiotic formulation was evaluated in C57BL/6 mice infected with Clostridium difficile (CD) NAP1/027. Antibiotic treated mice were divided into four groups. Group 1, fed with a synbiotic formulation consisting of Lactobacillus plantarum F44, L. paracasei F8, Bifidobacterium breve 46, B. lactis 8:8, galacto-oligosaccharides (GOS), isomalto-oligosaccharides (IMOS) and resistant starch (RS); group 2, fed with the same four probiotic strains as in group 1; group 3, fed with the same prebiotic supplements as mentioned in group 1 for seven days before CD infection and group 4, the control group, was antibiotic treated and infected with NAP1/027 strain. Faeces and caecal contents were... (More)
 - The protective effect of a multi-strain probiotic and synbiotic formulation was evaluated in C57BL/6 mice infected with Clostridium difficile (CD) NAP1/027. Antibiotic treated mice were divided into four groups. Group 1, fed with a synbiotic formulation consisting of Lactobacillus plantarum F44, L. paracasei F8, Bifidobacterium breve 46, B. lactis 8:8, galacto-oligosaccharides (GOS), isomalto-oligosaccharides (IMOS) and resistant starch (RS); group 2, fed with the same four probiotic strains as in group 1; group 3, fed with the same prebiotic supplements as mentioned in group 1 for seven days before CD infection and group 4, the control group, was antibiotic treated and infected with NAP1/027 strain. Faeces and caecal contents were collected for microbial cell viability, quantitative PCR (qPCR), toxin analyses and histopathology. Synbiotics and probiotics fed mice showed a significant increase of total bifidobacteria (P < 0.05). Total lactobacilli count was increased in group 1. The caecal toxins were negative in group 2 mice, and one sample each from group 1 and 3 was positive. qPCR of caecal content showed significant reduction in NAP1/027 DNA copies in group 1-2 and significantly higher numbers of B. breve 46, L. plantarum F44 and L. paracasei F8 in group 1 and 2 (P < 0.05) but much less pronounced in group 3-4. This study demonstrated that the newly developed synbiotic or multi-strain probiotic formulation conferred protection against NAP1/027 infection in C57BL/6 mice. This holds promising to conduct future human studies. (Less)
 
    Please use this url to cite or link to this publication:
    https://lup.lub.lu.se/record/4581359
- author
 - Kondepudi, Kanthi Kiran ; Ambalam, Padma ; Karagin, Peren H ; Nilsson, Ingrid LU ; Wadström, Torkel LU and Ljungh, Åsa LU
 - organization
 - publishing date
 - 2014
 - type
 - Contribution to journal
 - publication status
 - published
 - subject
 - in
 - Microbiology and Immunology
 - volume
 - 58
 - issue
 - 10
 - pages
 - 552 - 558
 - publisher
 - Center for Academic Publications Japan
 - external identifiers
 - 
                
- pmid:25059277
 - wos:000342912900002
 - scopus:84908874020
 - pmid:25059277
 
 - ISSN
 - 1348-0421
 - DOI
 - 10.1111/1348-0421.12184
 - language
 - English
 - LU publication?
 - yes
 - id
 - d997918a-94ae-446d-bc39-9aede036f472 (old id 4581359)
 - alternative location
 - http://www.ncbi.nlm.nih.gov/pubmed/25059277?dopt=Abstract
 - date added to LUP
 - 2016-04-01 09:53:09
 - date last changed
 - 2025-10-14 09:38:10
 
@article{d997918a-94ae-446d-bc39-9aede036f472,
  abstract     = {{The protective effect of a multi-strain probiotic and synbiotic formulation was evaluated in C57BL/6 mice infected with Clostridium difficile (CD) NAP1/027. Antibiotic treated mice were divided into four groups. Group 1, fed with a synbiotic formulation consisting of Lactobacillus plantarum F44, L. paracasei F8, Bifidobacterium breve 46, B. lactis 8:8, galacto-oligosaccharides (GOS), isomalto-oligosaccharides (IMOS) and resistant starch (RS); group 2, fed with the same four probiotic strains as in group 1; group 3, fed with the same prebiotic supplements as mentioned in group 1 for seven days before CD infection and group 4, the control group, was antibiotic treated and infected with NAP1/027 strain. Faeces and caecal contents were collected for microbial cell viability, quantitative PCR (qPCR), toxin analyses and histopathology. Synbiotics and probiotics fed mice showed a significant increase of total bifidobacteria (P < 0.05). Total lactobacilli count was increased in group 1. The caecal toxins were negative in group 2 mice, and one sample each from group 1 and 3 was positive. qPCR of caecal content showed significant reduction in NAP1/027 DNA copies in group 1-2 and significantly higher numbers of B. breve 46, L. plantarum F44 and L. paracasei F8 in group 1 and 2 (P < 0.05) but much less pronounced in group 3-4. This study demonstrated that the newly developed synbiotic or multi-strain probiotic formulation conferred protection against NAP1/027 infection in C57BL/6 mice. This holds promising to conduct future human studies.}},
  author       = {{Kondepudi, Kanthi Kiran and Ambalam, Padma and Karagin, Peren H and Nilsson, Ingrid and Wadström, Torkel and Ljungh, Åsa}},
  issn         = {{1348-0421}},
  language     = {{eng}},
  number       = {{10}},
  pages        = {{552--558}},
  publisher    = {{Center for Academic Publications Japan}},
  series       = {{Microbiology and Immunology}},
  title        = {{A novel multi-strain probiotic and synbiotic supplement for prevention of Clostridium difficile infection in a murine model.}},
  url          = {{http://dx.doi.org/10.1111/1348-0421.12184}},
  doi          = {{10.1111/1348-0421.12184}},
  volume       = {{58}},
  year         = {{2014}},
}